BeOne Medicines
ONC
#636
Rank
C$53.25 B
Marketcap
C$481.29
Share price
-1.23%
Change (1 day)
66.85%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

Market capitalization of BeOne Medicines (ONC)

Market cap: C$53.25 Billion

As of January 2026 BeOne Medicines has a market cap of C$53.25 Billion. This makes BeOne Medicines the world's 636th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of BeOne Medicines from 2016 to 2026

End of year Market Cap

Year Marketcap Change
2026C$53.25 B12.5%
2025C$47.34 B61.08%
2024C$29.38 B12.4%
2023C$26.14 B-24.24%
2022C$34.51 B-2.56%
2021C$35.41 B17.36%
2020C$30.17 B126.15%
2019C$13.34 B17.22%
2018C$11.38 B103.46%
2017C$5.59 B245.63%
2016C$1.61 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of BeOne Medicines was reported to be:

C$53.25 Billion
by Nasdaq info icon info icon
C$53.25 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Onconova Therapeutics
ONTX
C$29.01 M-99.95%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
C$1.43 B-97.31%๐Ÿ‡บ๐Ÿ‡ธ USA